Analysts: Synta Pharmaceuticals Corp (SNTA.OQ)

SNTA.OQ on NASDAQ Stock Exchange Global Market

6.09USD
1 Aug 2013
Price Change (% chg)

$-0.62 (-9.24%)
Prev Close
$6.71
Open
$6.64
Day's High
$6.90
Day's Low
$6.04
Volume
617,019
Avg. Vol
463,669
52-wk High
$11.77
52-wk Low
$3.77

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.29 December 2 Aug 2013

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 2 1 1 2
(3) HOLD 3 4 4 3
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.14 2.29 2.29 2.14

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 8 0.32 2.60 0.00 0.50
Quarter Ending Dec-13 8 1.50 9.38 0.00 0.50
Year Ending Dec-13 9 1.92 9.38 0.00 8.11
Year Ending Dec-14 8 7.98 53.31 0.00 32.00
Earnings (per share)
Quarter Ending Sep-13 8 -0.29 -0.21 -0.36 -0.32
Quarter Ending Dec-13 8 -0.29 -0.15 -0.36 -0.34
Year Ending Dec-13 9 -1.18 -0.88 -1.31 -1.04
Year Ending Dec-14 9 -1.12 -0.78 -1.35 -0.79

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 0.32 0.00 0.32 100.00
Quarter Ending Dec-12 0.45 0.00 0.45 100.00
Quarter Ending Sep-12 1.94 0.00 1.94 100.00
Quarter Ending Jun-12 0.51 0.00 0.51 100.00
Quarter Ending Mar-12 0.66 0.15 0.51 77.71
Earnings (per share)
Quarter Ending Mar-13 -0.27 -0.30 0.03 -12.15
Quarter Ending Dec-12 -0.26 -0.29 0.03 -10.94
Quarter Ending Sep-12 -0.23 -0.25 0.02 -7.76
Quarter Ending Jun-12 -0.27 -0.25 0.02 -5.91
Quarter Ending Mar-12 -0.25 -0.27 0.02 -9.44

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 0.32 0.32 0.32 0.32 0.50
Quarter Ending Dec-13 1.50 1.50 1.50 1.50 0.50
Year Ending Dec-13 1.92 1.92 1.92 1.92 8.11
Year Ending Dec-14 7.98 7.98 7.98 7.98 32.00
Earnings (per share)
Quarter Ending Sep-13 -0.29 -0.29 -0.29 -0.29 -0.32
Quarter Ending Dec-13 -0.29 -0.29 -0.29 -0.29 -0.34
Quarter Ending Dec-13 -1.18 -1.18 -1.18 -1.19 -1.04
Quarter Ending Dec-14 -1.12 -1.12 -1.12 -1.15 -0.79

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-13 0 0 0 0
Quarter Ending Dec-13 0 0 0 0
Year Ending Dec-13 0 0 0 0
Year Ending Dec-14 0 0 0 0
Earnings
Quarter Ending Sep-13 0 0 0 0
Quarter Ending Dec-13 0 0 0 0
Year Ending Dec-13 0 0 0 0
Year Ending Dec-14 0 0 0 1

Analyst Research Reports

Report Title Price
Provider: S&P Capital IQ Quantitative Report
$69.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$25.00
Provider: Wright Reports
$460.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks